Medicina Legal, Psiquiatría y Patología
Saila
University of Amsterdam
Ámsterdam, HolandaUniversity of Amsterdam-ko ikertzaileekin lankidetzan egindako argitalpenak (36)
2024
-
A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort
Schizophrenia Research, Vol. 266, pp. 237-248
-
PsyCog: A computerised mini battery for assessing cognition in psychosis
Schizophrenia Research: Cognition, Vol. 37
2023
-
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 13, pp. 6150-6160
-
Development and Validation of Predictive Model for a Diagnosis of First Episode Psychosis Using the Multinational EU-GEI Case-control Study and Modern Statistical Learning Methods
Schizophrenia Bulletin Open, Vol. 4, Núm. 1
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
-
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study
Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106
-
First-Episode Psychosis Patients Who Deteriorated in the Premorbid Period Do Not Have Higher Polygenic Risk Scores Than Others: A Cluster Analysis of EU-GEI Data
Schizophrenia bulletin, Vol. 49, Núm. 1, pp. 218-227
-
Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders
Psychological Medicine, Vol. 53, Núm. 13, pp. 5986-5991
-
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study
Psychological medicine, Vol. 53, Núm. 15, pp. 7418-7427
-
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications
Neuroscience and Biobehavioral Reviews, Vol. 149
-
Tobacco use in first-episode psychosis, a multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 15, pp. 7265-7276
-
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; The EU-GEI study
Psychological Medicine, Vol. 53, Núm. 8, pp. 3396-3405
2022
-
Childhood Maltreatment, Educational Attainment, and IQ: Findings from a Multicentric Case-control Study of First-episode Psychosis (EU-GEI)
Schizophrenia Bulletin, Vol. 48, Núm. 3, pp. 575-589
-
Facial Emotion Recognition in Psychosis and Associations With Polygenic Risk for Schizophrenia: Findings From the Multi-Center EU-GEI Case-Control Study
Schizophrenia bulletin, Vol. 48, Núm. 5, pp. 1104-1114
-
Genetic variants associated with longitudinal changes in brain structure across the lifespan
Nature neuroscience, Vol. 25, Núm. 4, pp. 421-432
-
Mapping genomic loci implicates genes and synaptic biology in schizophrenia
Nature, Vol. 604, Núm. 7906, pp. 502-508
-
Migration history and risk of psychosis: Results from the multinational EU-GEI study
Psychological Medicine, Vol. 52, Núm. 14, pp. 2972-2984
-
Perceived major experiences of discrimination, ethnic group, and risk of psychosis in a six-country case-control study
Psychological Medicine, Vol. 52, Núm. 15, pp. 3668-3676
2021
-
Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls
Psychological Medicine, Vol. 51, Núm. 12, pp. 2074-2082
-
Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: The EU-GEI case-control study
Psychological Medicine, Vol. 51, Núm. 8, pp. 1329-1337